Our response to COVID-19

We're supporting people to maintain their wellbeing and manage isolation.

Treatments for dual diagnosis

What is dual diagnosis?

Several treatments have been targeted to people with ‘dual diagnosis’; both a psychiatric disorder and a substance use disorder. Studies of dual diagnosis may investigate the availability and effectiveness of treatments for either diagnosis, including symptom severity, substance use, social functioning, quality of life, and also, cognition.

What is the evidence for treatments for dual diagnosis?

Overall, mostly low quality evidence is unclear of any benefit of pharmaceutical treatments for dual diagnosis.

Review authors conclude that valproate and lamotrigine may improve co-occurring mood and substance use outcomes, naltrexone may be effective for reducing excessive alcohol consumption, and citicoline may decrease cocaine use and enhance declarative memory.

July 2020

Last updated at: 2:32 am, 9th July 2020
To view documentation related to this topic download the files below
Fact Sheet Technical Commentary

NeuRA Libraries

Title Colour Legend:
Green - Topic summary is available.
Orange - Topic summary is being compiled.
Red - Topic summary has no current systematic review available.